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Abstract: Dengue fever has been a threat to public health not only in tropical regions but non-tropical
regions due to recent climate change. Motivated by a recent dengue outbreak in Japan, we develop
a two-patch model for dengue transmission associated with temperature-dependent parameters.
The two patches represent a park area where mosquitoes prevail and a residential area where people
live. Based on climate change scenarios, we investigate the dengue transmission dynamics between
the patches. We employ an optimal control method to implement proper control measures in the
two-patch model. We find that blockage between two patches for a short-term period is effective
in a certain degree for the disease control, but to obtain a significant control effect of the disease,
a long-term blockage should be implemented. Moreover, the control strategies such as vector control
and transmission control are very effective, if they are implemented right before the summer outbreak.
We also investigate the cost-effectiveness of control strategies such as vaccination, vector control
and virus transmission control. We find that vector control and virus transmission control are more
cost-effective than vaccination in case of Korea.
Keywords: dengue transmission; patch model; temperature-dependent parameters; control strategies;
climate change
1. Introduction
Dengue fever is a vector-borne disease spread by Aedes type mosquitoes such as Aedes aegypti
and Aedes albopictus. Since Aedes mosquitoes were generally found in tropical regions, dengue fever
has been known as a tropical disease [1]. However, recent dengue outbreaks are expanding beyond
the tropic regions by climate change due to global warming [2]. It has been reported that dengue
transmission is affected by the climate environment [3–5] and in particular, the temperature strongly
affects the dengue dynamics [6,7].
Recently, 160 cases of confirmed autochthonous dengue fever were reported in Tokyo, Japan,
and most of the confirmed cases have been exposed to mosquito bites at Yoyogi Park in the city [8,9].
In case of Korea, a neighboring country of Japan, although there is no autochthonous dengue case
yet, the dengue fever has been predicted to be one of the most probable major threats to public health
in the near future [10], and it has been shown that the frequency of the imported dengue cases in
Korea and Japan has a similar pattern [11]. Moreover, the number of the imported dengue cases have
been increasing recently in Korea [12]. In particular, Seoul, the most populated capital city of Korea,
has several big parks where mosquitoes prevail like Tokyo, and the city would be at a risk from dengue
transmission in the future [13].
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In this paper, we develop a mathematical model associated with temperature-dependent
parameters for describing dengue transmission between two patches which represent a park
area where the dengue vector inhabits and an urban area where humans reside. Based on the
Representative Concentration Pathway (RCP) climate change scenarios, we investigate the effect
of control strategies for the dengue transmission in the two-patch model using the optimal control
method and cost-effectiveness analysis.
2. Materials and Methods
2.1. Two-Patch Dengue Transmission Model
In this section, we develop a two-patch dengue transmission model by applying differential
equation approach. It is assumed that patch 1 is a park area where mosquitoes prevail, and patch 2
is a residential area where people live. The focus area for the model is Seoul Forest Park (patch 1)
and the residential area (patch 2) around the park in Seoul, Korea. A schematic diagram of the full
two-patch model is shown in Figure 1. The model considers the states of mosquito larvae (susceptible
(Sei) and infectious (Iei) by vertical infection), female adult mosquitoes (susceptible (Svi), exposed (Evi)
and infectious (Ivi)) and humans (susceptible (Shi), exposed (Ehi), infectious (Ihi) and recovered (Rhi)),
for patch i = 1, 2. We denote the total larvae population, female adult mosquito population and
human population by Nei, Nvi and Nhi for patch i = 1, 2. That is, Nei = Sei + Iei, Nvi = Svi + Evi + Ivi
and Nhi = Shi + Ehi + Ihi + Rhi. To describe the transmission dynamics in patch 2, we use the
dengue model in [14]. In our two-patch model, we assume that humans can move between patches,
but mosquitoes cannot.




























𝛿2(1 − 𝜈𝐼𝑣2/𝑁𝑣2) 𝛿2𝜈𝐼𝑣2/𝑁𝑣2
Patch 1 (park) Patch 2 (residential area)
Figure 1. Two-patch dengue transmission model.
We write the governing equations of the model as follows:
Patch 1
Vector
Ṡe1 = δ1 (1− νIv1/Nv1)−ωSe1 − µeSe1
İe1 = δ1νIv1/Nv1 −ωIe1 − µe Ie1
Ṡv1 = ωSe1 − βhvSv1 Ih1/Nh1 − µvSv1
Ėv1 = βhvSv1 Ih1/Nh1 − εEv1 − µvEv1
İv1 = εEv1 + ωIe1 − µv Iv1
Host
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Ṡh1 = p21Sh2 − βvhSh1 Iv1/Nh1 − p12Sh1
Ėh1 = p21Eh2 + βvhSh1 Iv1/Nh1 − αEh1 − p12Eh1
İh1 = p21(1− g)Ih2 + αEh1 − γIh1 − p12 Ih1




Ṡe2 = δ2 (1− νIv2/Nv2)−ωSe2 − µeSe2
İe2 = δ2νIv2/Nv2 −ωIe2 − µe Ie2
Ṡv2 = ωSe2 − βhvSv2 Ih2/Nh2 − µvSv2
Ėv2 = βhvSv2 Ih2/Nh2 − εEv2 − µvEv2
İv2 = εEv2 + ωIe2 − µv Iv2
Host
Ṡh2 = p12Sh1 + µhb(Nh1 + Nh2)− βvhSh2 Iv2/Nh2 − ηSh2 − µhd(Sh1 + Sh2)− p21Sh2
Ėh2 = p12Eh1 + βvhSh2 Iv2/Nh2 + ηSh2 − αEh2 − µhd(Eh1 + Eh2)− p21Eh2
İh2 = p12 Ih1 + αEh2 − γIh2 − µhd(Ih1 + Ih2)− p21(1− g)Ih2
Ṙh2 = p12Rh1 + γIh2 − µhd(Rh1 + Rh2)− p21Rh2
In the governing Equation (1), the parameters relevant to larvae and mosquitoes are described
as follows: ω is the maturation rate of pre-adult mosquitoes, and µv and µe are the mortality rate
of adult mosquitoes and larvae, respectively. ν and 1/ε denote the rate of vertical infection from
infected mosquitoes to eggs and the extrinsic incubation period, respectively, and δi is the number
of new recruits in the larva stage for patch i = 1, 2. The parameters βvh = bbh and βhv = bbv are the
transmissible rates from mosquito to human and from human to mosquito, respectively, where b is the
daily biting rate of a mosquito and bv and bh are the probability of infection from human to mosquito per
bite and the probability of infection from mosquito to human per bite, respectively [14]. The parameters
µhb and µhd represent the human birth rate and death rate, respectively, and the two rates are assumed
to be equal. The parameters 1/α and 1/γ are the latent period and infectious period for humans,
respectively. The inflow rate of infection due to international travelers is defined by η [14]. pij refers to
the human movement rate from patch i to j, where ∑2j=1 pij = 1 and 0 ≤ pij ≤ 1 for i = 1, 2. Since there
are about 7,500,000 visitors to Seoul Forest Park each year [15], approximately 20,550 people visit the
park daily. Hence, assuming Nh1(0) = 20, 000, Nh2(0) = 480, 000, i.e., the total human population
of both patches is 500, 000, we compute p21 = 20, 550/500, 000 = 0.0411. Moreover, we assume that
p11 = 0.001, which represents that a small number of people such as park keepers and homeless people
stay in the park, and p12 = 1− p11 = 0.999.
The parameters in the system (1) are described with their values in Table 1.
Table 1. Descriptions and values of parameters.
Symbol Description Value Reference
ν Vertical infection rate of Aedes albopictus mosquitoes 0.004 [16]
1/α Latent period for human (day) 5 [17]
1/γ Infectious period for human (day) 7 [7,16,18]
µhb Human birth rate (day−1) 0.000022 [19]
µhd Human death rate (day−1) 0.000022 Assumed
p21 Human movement rate from patch 2 to 1 (day−1) 0.0411 Estimated
p12 Human movement rate from patch 1 to 2 (day−1) 0.999 Assumed
g Proportion of dengue infections symptomatic in Ih2 0.45 [20]
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Table 1. Cont.
Symbol Description Value Reference
b Biting rate (day−1) ** [21]
bh Probability of infection per bite (v→h) ** [22]
bv Probability of infection per bite (h→v) ** [22]
µe Mortality rates of the larvae (day−1) ** [23]
µv Mortality rates of the mosquitoes (day−1) ** [24]
ω Pre-adult maturation rate (day−1) ** [24]
ε Virus incubation rate (day−1) ** [25]
βvh Transmissible rate (v→h) (day−1) bbh [22]
βhv Transmissible rate (h→v) (day−1) bbv [22]
δi Number of new recruits in the larvae stage µv Nvi + µe Nei [16]
for patch i = 1, 2 (day−1)
η Inflow rate of infection by international travelers (day−1) ** [14,26]
** denotes the temperature-dependent parameters described in Section 2.2.
2.2. Parameter Estimation
The temperature-sensitive parameters for the dengue mosquitoes have been studied in previous
researches [14,16,21–25]. Using the previous results, we describe the parameters sensitive to the
temperature as the following temperature-dependent functions.





40.08− T (13.35 ◦C ≤ T ≤ 40.08 ◦C)
0 (T < 13.35 ◦C, T > 40.08 ◦C)
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0 (T < 17.05 ◦C, T > 35.83 ◦C)





37.46− T (12.22 ◦C ≤ T ≤ 37.46 ◦C)
0 (T < 12.22 ◦C, T > 37.46 ◦C)
(4) The mortality rate µv of the adult mosquito is [21]
µv(T) =
{
1/(−1.43(13.41− T)(31.51− T)) (13.41 ◦C ≤ T ≤ 31.51 ◦C)
1 (T < 13.41 ◦C, T > 31.51 ◦C)





39.66− T (8.60 ◦C ≤ T ≤ 39.66 ◦C)
0 (T < 8.60 ◦C, T > 39.66 ◦C)





43.05− T (10.39 ◦C ≤ T ≤ 43.05 ◦C)
0 (T < 10.39 ◦C, T > 43.05 ◦C)
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(7) The mortality rate µe of larva (aquatic phase mortality rate) is [24]
µe = 2.130− 0.3797T + 0.02457T2 − 0.0006778T3 + 6.794× 10−6T4.
(8) The number of new recruits in the larvae stage δ for patch i = 1, 2 is computed as [14]
δi = µvNvi + µeNei.
Figure 2 illustrates the the graph of the temperature-dependent parameters.













































Figure 2. Plots of the temperature-dependent parameters; (a) transmissible rates βhv and βvh, (b) vector
mortality rates µv and µe, (c) pre-adult maturation rate ω and (d) virus incubation rate ε.
For the temperature data, we utilize RCP scenarios, which provide four representative scenarios
such as the low level scenario (RCP 2.6), the two medium level scenarios (RCP 4.5/6.0) and the high
level scenario (RCP 8.5) [27]. Since patch 1, Seoul Forest Park, is located in Seongdong-gu, Seoul,
the RCP temperature data for Seongdong-gu is used in the simulation. One can see the tendency of the
temperature rise between 2030 and 2100 according to the RCP scenarios (refer to Appendix A).
2.3. The Seasonal Reproduction Number
The basic reproduction number is important in epidemiology since it measures the expected
number of infectious cases directly caused by one infectious case in a susceptible population. It is
known that if R0 < 1, the system has a locally asymptotically stable disease-free equilibrium, but if
R0 > 1, it has an unstable disease-free equilibrium [28]. However, when some model parameters are
time-dependent as in Table 1, one has to use the seasonal reproduction number Rs instead of the basic
reproduction number [29].
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Theorem 1. The seasonal reproduction number Rs corresponding to a single patch model with only patch 2












Proof. The proof of the theorem can be found in Appendix B.
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Proof. The proof of the theorem can be found in Appendix B.
Figure 3 shows the seasonal reproduction number Rs for three years from 1 January 2030 for
each RCP scenario. It is observed that the value of Rs is much higher than 1 in the summer season
for all RCP scenarios. This implies that it is very likely that the dengue outbreak will occur during
the summer.





























Figure 3. Plots of the seasonal reproduction number Rs for Representative Concentration Pathways
(RCPs) 2.6, 4.5, 6.0 and 8.5 during three years.
3. Results
3.1. Dengue Transmission Dynamics Based on Rcp Scenarios
In this section, we perform numerical simulations for the two patch model based on RCP
scenarios. For each simulation, we assume the initial condition as Nh1(0) = 20, 000, Nh2(0) = 480, 000,
Nv1(0) = 0.5× Nh(0), Nv2(0) = Nh(0), where Nh(0) = Nh1(0) + Nh2(0). Moreover, we assume that
there are no infected mosquitoes and humans initially, that is, Iei(0) = Evi(0) = Ivi(0) = 0 and
Ehi(0) = Ihi(0) = 0 for i = 1, 2, so that the first infection in the model is initiated by the inflow of
infected international travelers. Figure 4 shows the time evolution of human incidence and cumulative
human incidence from January 1 in 2030 for 10 years in the model without control for each RCP
scenario. One can see that there will be more dengue incidences for RCP 2.6 and 8.5 than RCP 4.5 and
6.0, which implies that the two extreme level RCP scenarios might provide more favorable temperature
environment for dengue virus transmission than the two medium level RCP scenarios.
3.2. The Effects of Human and Vector Controls
In the case of the dengue outbreak in Tokyo, Yoyogi park in the city was known as an infection
hub and the closure of the park turned out to be very effective control strategies [8]. In accordance
with the case in Tokyo, it is worth investigating the effects of the control strategies including the park
closure as well as vector and human controls for our model (1). We assume that the park closure begins
when the cumulative incidence is over 10. In order to see the control effect of the park closure, we set
p12 = p21 = 0, and all human population stays in the city area (patch 2). Figure 5 shows the effect
of park closure for duration 3, 5, 10, 30, 60 days. It is observed that the park closure for a short-term
period such as 3 and 5 days would be effective in a certain degree and the closure for a long-term
period such as 30 and 60 days would make a significant control effect for all RCP scenarios.

















































































Figure 4. Human incidence (top) and cumulative human incidence (bottom) for 10 years from 2030
without control.
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Figure 5. The effect of the park closure (CL) for duration 0, 3, 5, 10, 30 and 60 days on human
incidence (top) and cumulative human incidence (bottom). Park closure for duration 0 means there is
no park closure.
Concerning the control for mosquitoes and humans, it was estimated that the current level of
control for mosquitoes in Korea is about 2% increase of mosquito death rate and 2% decrease of
transmissible rate between mosquitoes and humans, respectively, and these control measures were
implemented between May and October in each year [29].
Now we compare the control effects of the vector death rate, dengue transmissible rate and park
closure. In Figure 6, it is assumed that the controls of the vector death rate and dengue transmissible
rate are implemented as a 2% increase and a 2% decrease of the rates, respectively, and the park closure
is made for only 30 days in the year 2030 at the early stage of the dengue outbreak. Figure 6 shows
that the vector control is more effective than the transmission control, and the combination of the park
closure and vector and human control is most effective.
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and combination of transmission control, vector control and park closure.
3.3. Optimal Control
In this section, we implement effective control measures by formulating an optimal control
problem for the two-patch dengue model. By incorporating the control functions (1− u1) and (1 + u2)
into the transmissible rate between the vector and human and the mortality rate of the vector in each
patch, respectively, in the model Equation (1), we obtain the controlled two-patch system (2) as follows:
Patch 1
Vector
Ṡe1 = δ1 (1− νIv1/Nv1)−ωSe1 − µeSe1
İe1 = δ1νIv1/Nv1 −ωIe1 − µe Ie1
Ṡv1 = ωSe1 − (1− u1)βhvSv1 Ih1/Nh1 − (1 + u2)µvSv1
Ėv1 = (1− u1)βhvSv1 Ih1/Nh1 − εEv1 − (1 + u2)µvEv1
İv1 = εEv1 + ωIe1 − (1 + u2)µv Iv1
Figure 6. Comparison of cumulative incidences under different control strategies: no control,
transmission control, vector (mosquito death) control, combination of transmission and vector controls
and combination of transmission control, vector control and park closure.
3.3. Optimal Control
In this section, we implement effective control measures by formulating an optimal control
problem for the two-patch dengue model. By incorporating the control functions (1− u1) and (1 + u2)
into the transmissible rate between the vector and human and the mortality rate of the vector in each
patch, respectively, in the model Equation (1), we obtain the controlled two-patch system (2) as follows:
Patch 1
Vector
Ṡe1 = δ1 (1− νIv1/Nv1)−ωSe1 − µeSe1
İe1 = δ1νIv1/Nv1 −ωIe1 − µe Ie1
Ṡv1 = ωSe1 − (1− u1)βhvSv1 Ih1/Nh1 − (1 + u2)µvSv1
Ėv1 = (1− u1)βhvSv1 Ih1/Nh1 − εEv1 − (1 + u2)µvEv1
İv1 = εEv1 + ωIe1 − (1 + u2)µv Iv1
Host
Ṡh1 = p21Sh2 − (1− u1)βvhSh1 Iv1/Nh1 − p12Sh1
Ėh1 = p21Eh2 + (1− u1)βvhSh1 Iv1/Nh1 − αEh1 − p12Eh1
İh1 = p21(1− g)Ih2 + αEh1 − γIh1 − p12 Ih1




Ṡe2 = δ2 (1− νIv2/Nv2)−ωSe2 − µeSe2
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İe2 = δ2νIv2/Nv2 −ωIe2 − µe Ie2
Ṡv2 = ωSe2 − (1− u1)βhvSv2 Ih2/Nh2 − (1 + u2)µvSv2
Ėv2 = (1− u1)βhvSv2 Ih2/Nh2 − εEv2 − (1 + u2)µvEv2
İv2 = εEv2 + ωIe2 − (1 + u2)µv Iv2
Host
Ṡh2 = p12Sh1 + µhb(Nh1 + Nh2)− (1− u1)βvhSh2 Iv2/Nh2 − ηSh2 − µhd(Sh1 + Sh2)− p21Sh2
Ėh2 = p12Eh1 + (1− u1)βvhSh2 Iv2/Nh2 + ηSh2 − αEh2 − µhd(Eh1 + Eh2)− p21Eh2
İh2 = p12 Ih1 + αEh2 − γIh2 − µhd(Ih1 + Ih2)− p21(1− g)Ih2
Ṙh2 = p12Rh1 + γIh2 − µhd(Rh1 + Rh2)− p21Rh2
Now we set up an optimal control problem for the two-patch model in order to minimize the
proportions of infected vectors and humans in both patches for a finite time interval at a minimal cost














where W1 and W2 denote the weight constants on the infected humans and vectors and the total
vectors, respectively, and W3 and W4 denote the weight constants that are the relative costs of the
implementation of the preventive controls for decreasing the transmissible rate between vector and
human and increasing the mortality rate of the vector, respectively.
Then, we find an optimal solution (U∗, X∗) that satisfies
J(U∗) = min{J(U) | U ∈ Ω},
where Ω = {ui(t) ∈ (L1(0, t f ))2 ‖ a ≤ ui(t) ≤ b, t ∈ [0, t f ], i = 1, 2} subject to the state equations
with X = (Se1, Ie1, Sv1, Ev1, Iv1, Sh1, Eh1, Ih1, Rh1, Se2, Ie2, Sv2, Ev2, Iv2, Sh2, Eh2, Ih2, Rh2) and U = (u1, u2).
It is known that the standard results of optimal control theory guarantees the existence of optimal
controls, and the necessary conditions of optimal solutions can be derived from Pontryagin maximum
principle [31,32]. The Pontryagin maximum principle converts the system (2) into the problem of
minimizing the Hamiltonian H given by







+ λ1[δ1 (1− νIv1/Nv1)−ωSe1 − µeSe1] + λ2[δ1νIv1/Nv1 −ωIe1 − µe Ie1]
+ λ3[ωSe1 − βhv(1− u1(t))Sv1 Ih1/Nh1 − µv(1 + u2(t))Sv1]
+ λ4[βhv(1− u1(t))Sv1 Ih1/Nh1 − εEv1 − µv(1 + u2(t))Ev1]
+ λ5[εEv1 + ωIe1 − µv(1 + u2(t))Iv1]
+ λ6[p21Sh2 − βvh(1− u1(t))Sh1 Iv1/Nh1 − p12Sh1]
+ λ7[p21Eh2 + βvh(1− u1(t))Sh1 Iv1/Nh1 − αEh1 − p12Eh1]
+ λ8[p21(1− g)Ih2 + αEh1 − γIh1 − p12 Ih1] (4)
+ λ9[δ2 (1− νIv2/Nv2)−ωSe2 − µeSe2] + λ10[δ2νIv2/Nv2 −ωIe2 − µe Ie2]
+ λ11[ωSe2 − βhv(1− u1(t))Sv2 Ih2/Nh2 − µv(1 + u2(t))Sv2]
+ λ12[βhv(1− u1(t))Sv2 Ih2/Nh2 − εEv2 − µv(1 + u2(t))Ev2]
+ λ13[εEv2 + ωIe2 − µv(1 + u2(t))Iv2]
+ λ14[p12Sh1 + µhb(Nh1 + Nh2)− βvh(1− u1(t))Sh2 Iv2/Nh2 − ηSh2 − µhd(Sh1 + Sh2)− p21Sh2]
+ λ15[p12Eh1 + βvh(1− u1(t))Sh2 Iv2/Nh2 + ηSh2 − αEh2 − µhd(Eh1 + Eh2)− p21Eh2]
+ λ16[p12 Ih1 + αEh2 − γIh2 − µhd(Ih1 + Ih2)− p21(1− g)Ih2]
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Using the Hamiltonian H and the Pontryagin maximum principle, we obtain the theorem.
Theorem 3. There exist optimal controls U∗(t) and state solutions X∗(t) which minimize J(U) over Ω in (3).
In order for the above statement to be true, it is necessary that there exist continuous functions λj(t) such that
λ̇1 = (λ1 − λ2)µeνIv1/Nv1 + (λ1 − λ3)ω, λ̇2 = (λ1 − λ2)µeνIv1/Nv1 − (λ1 − λ2)µe + (λ2 − λ5)ω
λ̇3 = −W2 − λ1µv − (λ1 − λ2)µe Ne1νIv1/N2v1 + (λ3 − λ4)βhv(1− u1)Ih1/Nh1 + λ3µv(1 + u2)
λ̇4 = −W2 − λ1µv − (λ1 − λ2)µe Ne1νIv1/N2v1 + (λ4 − λ5)ε + λ4µv(1 + u2)
λ̇5 = −W1 −W2 − λ1µv + (λ1 − λ2)ν(µv + µe Ne1(Sv1 + Ev1)/N2v1) + (λ6 − λ7)βvh(1− u1)Sh1/Nh1
+λ5µv(1 + u2)
λ̇6 = (λ6 − λ7)βvh(1− u1)Iv1/Nh1 + (λ6 − λ14)p12 + λ14µhd
λ̇7 = (λ7 − λ8)α + (λ7 − λ15)p12 + λ15µhd
λ̇8 = −W1 + (λ3 − λ4)βhv(1− u1)Sv1/Nh1 + (λ8 − λ16)p12 + λ8γ + λ16µhd
λ̇9 = (λ9 − λ10)µeνIv2/Nv2 + (λ9 − λ11)ω, λ̇10 = (λ9 − λ10)µeνIv2/Nv2 − (λ9 − λ10)µe + (λ10 − λ13)ω
λ̇11 = −W2 − λ9µv − (λ9 − λ10)µe Ne2νIv2/N2v2 + (λ11 − λ12)βhv(1− u1)Ih2/Nh2 + λ11µv(1 + u2)
λ̇12 = −W2 − λ9µv − (λ9 − λ10)µe Ne2νIv2/N2v2 + (λ12 − λ13)ε + λ12µv(1 + u2)
λ̇13 = −W1 −W2 − λ9µv + (λ9 − λ10)ν(µv + µe Ne2(Sv2 + Ev2)/N2v2) + (λ14 − λ15)βvh(1− u1)Sh2/Nh2
+λ13µv(1 + u2)
λ̇14 = (λ14 − λ15)βvh(1− u1)Iv2/Nh2 + (λ14 − λ15)η − (λ6 − λ14)p21 + λ14µhd
λ̇15 = (λ15 − λ16)α− (λ7 − λ15)p21 + λ15µhd
λ̇16 = −W1 + (λ11 − λ12)βhv(1− u1)Sv2/Nh2 − (λ8 − λ16)p21(1− g) + λ16(γ + µhd)


































(λ3Sv1 + λ4Ev1 + λ5 Iv1 + λ11Sv2 + λ12Ev2 + λ13 Iv2)
}
, b}
Proof. The proof of the theorem can be found in Appendix B.
We assume the control duration as 5 years throughout the simulations, and the upper bound for
ui, i = 1, 2 is 0.1, since the control resources are limited. In Figures 7–9, we simulate the effects on
incidence and optimal control functions from different control strategies when only the transmissible
rates βhv, βvh are controlled, only the mortality rate µv is controlled and both the transmissible rates
βhv, βvh and the mortality rate µv are controlled, respectively. Considering the ratio of the number
of infected vectors and humans to the total number of vectors, we use the weight constants W1 = 1,
W2 = 0.0001, W3 = 1000 and W4 = 2000 for Figures 7–9. Figure 7 suggests that when the transmission
control is considered, it is effective to focus on the control during the summer. Moreover, Figure 8
shows that the peaks of u2 occasionally occurred, and Figure 9 implies that when all βhv, βvh and µv
are controlled, the control period of µv is longer than βhv and βvh. These results imply that it is more
effective if the controls are concentrated right before the summer outbreak, since seasonal patterns are
observed in all cases. For more cases with different weight constants, refer to Appendix C.
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Figure 7. The effect of control of transmissible rates βhv, βvh on the incidences and the optimal control
function u1.
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Figure 8. The effect of control of the mortality rate µv on the incidences and the optimal control
function u2.
3.4. Vaccination Model and Cost-Effectiveness of Control Strategies
Recently the vaccine for dengue such as Dengvaxia has been used to prevent dengue transmission
in the dengue-endemic countries including Mexico, Philippines, Indonesia and Brazil [33]. A recent
research investigated the cost-effectiveness of dengue vaccination in Mexico [20], which concluded
that a proper dengue vaccination program would be very cost-effective and also highly reduce the
dengue cases and casualties. Thus, it is worth investigating the cost-effectiveness of control strategies
including vaccination in our two-patch model. We assume that the vaccination will begin at the year
2030 and any susceptible individual, either seropositive or seronegative, can be vaccinated.
In order to consider the effect of the vaccination, we first construct a two-patch dengue
transmission model with vaccination by modifying the model (1). The model with vaccination






hi which denote the vaccinated susceptible,
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exposed, infected and recovered human class in patch i = 1, 2, respectively. The schematic diagram for
the model is shown in Figure 10.
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Figure 9. The effect of control of βhv, βvh and µv on the incidences and the optimal control functions
u1, u2.
Patch 1 (park) Patch 2 (residential area)
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Figure 10. Two-patch dengue transmission model with vaccination.
The governing equation for the model is written as follows:
Patch 1
Vector
Ṡe1 = δ1 (1− νIv1/Nv1)−ωSe1 − µeSe1
İe1 = δ1νIv1/Nv1 −ωIe1 − µe Ie1
Ṡv1 = ωSe1 − βhvSv1(Ih1 + IVh1)/Nh1 − µvSv1
Ėv1 = βhvSv1(Ih1 + I
V
h1)/Nh1 − εEv1 − µvEv1
İv1 = εEv1 + ωIe1 − µv Iv1
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Host (5)
Ṡh1 = p21Sh2 − βvhSh1 Iv1/Nh1 + ψSVh1 − p12Sh1
Ėh1 = p21Eh2 + βvhSh1 Iv1/Nh1 − αEh1 − p12Eh1
İh1 = p21(1− g)Ih2 + αEh1 − γIh1 − p12 Ih1
Ṙh1 = p21Rh2 + γIh1 − p12Rh1
ṠVh1 = p21S
V
h2 − βvh(1− κ)SVh1 Iv1/Nh1 − ψSVh1 − p12SVh1
ĖVh1 = p21E
V
h2 + βvh(1− κ)SVh1 Iv1/Nh1 − αvEVh1 − p12EVh1
İVh1 = p21(1− gv)IVh2 + αvEVh1 − γv IVh1 − p12 IVh1
ṘVh1 = p21R
V





Ṡe2 = δ2 (1− νIv2/Nv2)−ωSe2 − µeSe2
İe2 = δ2νIv2/Nv2 −ωIe2 − µe Ie2
Ṡv2 = ωSe2 − βhvSv2(Ih2 + IVh2)/Nh2 − µvSv2
Ėv2 = βhvSv2(Ih2 + I
V
h2)/Nh2 − εEv2 − µvEv2
İv2 = εEv2 + ωIe2 − µv Iv2
Host
Ṡh2 = p12Sh1 + µhb(Nh1 + Nh2)− βvhSh2 Iv2/Nh2 − ηSh2 − φSh2 + ψSVh2 − µhd(Sh1 + Sh2)− p21Sh2
Ėh2 = p12Eh1 + βvhSh2 Iv2/Nh2 + ηSh2 − αEh2 − µhd(Eh1 + Eh2)− p21Eh2
İh2 = p12 Ih1 + αEh2 − γIh2 − µhd(Ih1 + Ih2)− p21(1− g)Ih2
Ṙh2 = p12Rh1 + γIh2 − µhd(Rh1 + Rh2)− p21Rh2
ṠVh2 = p12S
V
h1 − βvh(1− κ)SVh2 Iv2/Nh2 + φSh2 − ψSVh2 − µhd(SVh1 + SVh2)− p21SVh2
ĖVh2 = p12E
V
h1 + βvh(1− κ)SVh2 Iv2/Nh2 − αvEVh2 − µhd(EVh1 + EVh2)− p21EVh2




h2 − γv IVh2 − µhd(IVh1 + IVh2)− p21(1− gv)IVh2
ṘVh2 = p12R
V
h1 + γv I
V
h2 − µhd(RVh1 + RVh2)− p21RVh2,
where the parameter ψ denotes the rate at which vaccine wanes off and the vaccination rate φ followed
by antibody formation is computed by φ = − ln(1−a)b , where a is the proportion of the vaccinated
humans and b is the vaccination period. Here, we assume a = 0.3 and b = 120 days between June and
September. The parameters relevant to vaccination are described in Table 2.
Table 2. Descriptions and values of parameters used in the model (5).
Symbol Description Value Reference
κ Vaccine efficacy against infection 0.616 [34]
1/αv Latent period for vaccinated human 5 Assumed
1/γv Infectious period for vaccinated human 7 Assumed
gv Proportion of symptomatic infection 0.8 [35]
in the vaccinated class
φ Vaccination rate 0.0030 Estimated
ψ Immunity reduction rate 0.0019 Estimated
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We evaluate the cost-effectiveness of the control measures such as vector control, dengue
virus transmission control, and vaccination by using the incremental cost-effectiveness ratio (ICER)
in terms of dollars per quality-adjusted life year (QALY) gained for a range of control costs.
The cost-effectiveness of a control strategy is related to the costs per disability-adjusted life years
(DALY) and gross domestic product (GDP) per capita; (i) a control strategy is very cost-effective if the
costs per DALY are less than GDP per capita, (ii) cost-effective if the costs per DALY are between GDP
per capita and 3× GDP per capita and (iii) not cost-effective if the costs per DALY are greater than 3×
GDP per capita [20,36]. The QALY function Q is computed as follows [20,37]:
Q(D, L, a) = −DCe
−ha
(h + r)2
[e−(h+r)L{1 + (h + r)(L + a)} − {1 + a(h + r)}]
where D is the disability weight for dengue fever(DF), dengue hemorrhagic fever(DHF) and death,
which are denoted by DDF, DDHF and DDeath, respectively, C is the age-weighting correction constant,
h is the parameter from the age-weighting function, a is the average age, L is the duration of the
disability or the years of life lost due to premature death expressed in years such as LDF, LDHF or LDeath




















where the rates of new DF, DHF and death cases for the vector and transmission control are
d(DF)
dt
= g(1− h)α(Eh1 + Eh2)
d(DHF)
dt







and the rates for the vaccination case are
d(DF)
dt
= g(1− h)α(Eh1 + Eh2) + gv(1− hv)αv(EVh1 + EVh2)
d(DHF)
dt









The total cost is obtained by the sum of the cost for direct control along the control strategies and
the cost associated with dengue infection under the observation period Tf . The direct controls we
consider are vector control, transmission control and vaccination where the costs of each direct control
are Cµv , Cβ and CV , respectively. The costs associated with dengue infection DF and DHF are CDF and
CDHF, respectively, where each cost is estimated from [20]. The total cost (TC) for each control strategy
is computed as follows:
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The parameters relevant to cost-effectiveness are described in Table 3.
Table 3. Descriptions and values of parameters for cost-effectiveness.
Symbol Description Value Reference
r Social discount rate for DALYs calculations 0.03 [37,38]
b Parameter of the age-weighting function 0.04 [37,38]
h Probability of developing DHF/DSS * 0.045 × 0.25 [20,35]
after symptomatic infection without vaccine
hv Probability of developing DHF/DSS 0.045 [35]
after symptomatic infection with vaccine
C Age-weighting correction constant 0.16243 [37,38]
CDF Direct medical cost for DF 293 [20]
CDHF Direct medical cost for DHF 1171 [20]
DDeath Disability weight for death 1 [20]
DDF Disability weight for DF 0.197 [39,40]
DDHF Disability weight for DHF 0.545 [39,40]
LDeath Years of life lost due to death 42 [20]
LDF Time lost due to DF (years) 0.019 [40]
LDHF Time lost due to DHF/DSS (years) 0.0325 [40]
a Average age of dengue exposure 28 [41]
χ Risk of death from DHF/DSS 0.01 [20,42]
* DSS = dengue shock syndrome.
In order to evaluate the cost-effectiveness of controls, we use the incremental cost-effectiveness
ratio (ICER) which is calculated by dividing the difference in total costs (incremental cost) by the
difference in the QALY with and without control cases. Figure 11 shows ICER per DALY averted
for the vaccination, vector control and transmission control cases. Here we assume, as in Section 3.2,
that the vector control and transmission control are implemented as a 2% increase of mosquito death
rate and a 2% decrease of transmissible rate between May and October, respectively. According to
recent researches, it was estimated that the cost of vaccination per capita is hundreds of USD [20,43],
while the cost per capita of the vector control and the transmission control ranges from tens of cents to
a few dollars in USD [44,45]. Thus, the results of Figure 11 imply that vector control and transmission
control are relatively more cost-effective than vaccination, and vaccination is not a suitable control
strategy in Korea in terms of cost-effectiveness.
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Figure 11. Incremental cost-effectiveness ratio (ICER) in log10 scale for the vaccinate, vector control
and transmission control cases.
4. Discussion and Conclusions
In this paper, we developed the two-patch dengue transmission model associated with
temperature-dependent parameters. The focus area for the model was Seoul Forest Park (patch 1)
and the residential area (patch 2) around the park in Seoul, the most populated city in Korea.
In the model, we represented the parameters sensitive to temperature as the temperature-dependent
nonlinear functions using the previous literatures. Using the temperature data under RCP climate
change scenarios, we investigated the dengue transmission dynamics within and between patches.
The simulation results for the model showed that if a dengue infection is initiated by the inflow of
infected international travelers into the focus area, there will be thousands of infected humans within
10 years in the case of no controls for the dengue disease.
We derived the formulas for the seasonal reproduction number Rs for the single-patch (patch 2)
and the two-patch model by using the next generation matrix. The simulation results (Figure 3) for
Rs showed that the value of Rs is much bigger than 1 in the summer season for all RCP scenarios.
This implies that it is very likely that the dengue outbreak will occur during the summer in the
near future, if there is no proper control strategy. To reduce the potential of the dengue outbreak,
proper control strategies should be implemented.
We studied optimal control strategies by using an optimal control framework under different
scenarios. We found that the control strategies are effective if they are implemented right before the
summer outbreak. Concerning the park closure, we found that the closure for a short-term period such
as 3 and 5 days would be effective in a certain degree, but the closure for a long-term period such as 30
and 60 days would make a substantial control effect.
By incorporating the vaccination policy into the two-patch model, we constructed the two-patch
dengue transmission model (5) with vaccination. Concerning the vaccination, currently Dengvaxia
is vaccinated for seropositive cases and also other vaccines are now in clinical development [46,47].
Since our model simulation begins at the year 2030, there is a possibility of the development of other
vaccines which can be used for any susceptible cases, either seropositive or seronegative. In light of
this aspect, in the vaccination model (5), we assume that any susceptible individual, seropositive or
seronegative, can be vaccinated. We investigated the cost-effectiveness of the control policies such as
vaccination, vector control, and transmission control, using the incremental cost-effectiveness ratio
(ICER) in terms of dollars per quality-adjusted life year (QALY). We found that the transmissible rate
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control and the vector control are cost-effective while the vaccination is less cost-effective. This result
is not compatible with the result in Mexico [20] because there are not a sufficient number of infective
humans in Korea, compared to the case of Mexico.
Since there have been no autochthonous dengue cases in Korea yet, the parameters relevant
to the cost of the dengue vaccination were adapted from the previous studies in dengue-endemic
regions [20,39,40]. Moreover, to the best of our knowledge, there have been no studies about the
relation between the cost and effectiveness of the dengue control in Korea. Although these factors
may result in a limitation in the accurate estimation of the cost-effectiveness for the control strategies,
the simulation results (Figure 11) clearly show the difference in cost-effectiveness between different
strategies; when the control resources are limited, it is more effective to implement vector control and
transmission control rather than vaccination.
In this research, we used the regional data such as temperature and human movement rate for
Seoul, Korea. Thus, most of the results presented in this paper may not be applied directly to the area
with different environment for mosquitoes and humans, but we expect that the modeling approach
presented in this work will be applied to other cases, especially when the temperature-dependent
transmission dynamics between endemic and non-endemic regions are investigated.
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Appendix A. Temperature Data under RCP Scenarios
The Intergovernmental Panel on Climate Change has developed RCP scenarios in 2014,
and four representative scenarios are the lowest-level scenario (RCP 2.6), the two medium level
scenarios (RCP 4.5/6.0) and the high-level scenario (RCP 8.5) [27]. In this paper, we use the daily climate
data estimated by the Korea Meteorological Administration under the four RCP scenarios. Figure A1
illustrates the 5-year averages of daily temperature and the ranges from the mean temperature in the
summer (June to August) to the mean temperature in the winter (December to February) for five years
in Seongdong-gu, Seoul from year 2030 to 2099.
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Figure A1. (a) Daily mean temperature for five years. (b) Range from the mean temperature in the
summer (June to August) to the mean temperature in the winter (December to February) for five years.
Appendix B. Proofs of Theorems 1, 2 and 3
Proof of Theorem 1. The system for the single-patch model with only patch 2 has the disease-free




















−ωIe − εEv + µv Iv
(α + µhd)Eh
−αEh + (γ + µhd)Ih
 .
Here F (x) denotes all of the new infections and V(x) denotes the net transition rates of the
corresponding compartment. F and V are 5 × 5 matrices at x0 given by
F =

0 0 δ2νNv 0 0
0 0 0 0 βhvSvNh
0 0 0 0 0
0 0 βvhShNh 0 0




ω + µe 0 0 0 0
0 ε + µv 0 0 0
−ω −ε µv 0 0
0 0 0 α + µhd 0
0 0 0 −α γ + µhd

Processes 2020, 8, 781 20 of 26
Hence, the next generation matrix G is computed as







µv Nv 0 0












0 0 0 0 0

Since the seasonal reproduction number Rs for the single-patch model is the dominant eigenvalue












Proof of Theorem 2. The system (1) has the disease-free state x0 = (Sei, 0, Svi, 0, 0, Shi, 0, 0, 0) with
η = 0. Let x = (Iei, Evi, Ivi, Ehi, Ihi)T for i = 1, 2. If F (x) and V(x) denote the functions for all of the


































−ωIe1 − εEv1 + µv Iv1
−ωIe2 − εEv2 + µv Iv2
−p21Eh2 + (α + p12)Eh1
(µhd − p12)Eh1 + (α + µhd + p21)Eh2
−p21(1− g)Ih2 − αEh1 + (γ + p12)Ih1
(µhd − p12)Ih1 − αEh2 + (γ + µhd + p21(1− g))Ih2

.
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Thus, F and V are 10 × 10 matrices at x0 given by
F =

0 0 0 0 δ1νNv1 0 0 0 0 0
0 0 0 0 0 δ2νNv2 0 0 0 0
0 0 0 0 0 0 0 0 βhvSv1Nh1
0
0 0 0 0 0 0 0 0 0 βhvSv2Nh2
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 βvhSh1Nh1
0 0 0 0 0
0 0 0 0 0 βvhSh2Nh2
0 0 0 0
0 0 0 0 0 0 0 0 0 0





ω + µe 0 0 0 0 0 0 0 0 0
0 ω + µe 0 0 0 0 0 0 0 0
0 0 ε + µv 0 0 0 0 0 0 0
0 0 0 ε + µv 0 0 0 0 0 0
−ω 0 −ε 0 µv 0 0 0 0 0
0 −ω 0 −ε 0 µv 0 0 0 0
0 0 0 0 0 0 α + p12 −p21 0 0
0 0 0 0 0 0 µhd − p12 α + µhd + p21 0 0
0 0 0 0 0 0 −α 0 γ + p12 −p21(1− g)
0 0 0 0 0 0 0 −α µhd − p12 γ + µhd + p21(1− g)






G1,1 0 G1,3 0 G1,5 0 0 0 0 0
0 G2,2 0 G2,4 0 G2,6 0 0 0 0
0 0 0 0 0 0 G3,7 G3,8 G3,9 G3,10
0 0 0 0 0 0 G4,7 G4,8 G4,9 G4,10
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
G7,1 0 G7,3 0 G7,5 0 0 0 0 0
0 G8,2 0 G8,4 0 G8,6 0 0 0 0
0 0 0 0 0 0 0 0 0 0





(ω + µe)µv Nv1
, G1,3 =
εδ1ν






(ω + µe)µv Nv2
, G2,4 =
εδ2ν





αSv1 βhv((1− g)p21(α + p21 + p12) + (γ + µhd)(α + p21 + µhd))
Nh1(α + p12 + p21)(γ + p12 + (1− g)p21)(α + µhd)(γ + µhd)
G3,8 =
αp21Sv1 βhv((1− g)(α + p21 + p12) + γ + µhd)
Nh1(α + p12 + p21)(γ + p12 + (1− g)p21)(α + µhd)(γ + µhd)
G3,9 =
Sv1 βhv(γ + (1− g)p21 + µhd)
Nh1(γ + p12 + (1− g)p21)(γ + µhd)
G3,10 =
(1− g)p21Sv1 βhv
Nh1(γ + p12 + (1− g)p21)(γ + µhd)
G4,7 =
α(p12 − µhd)Sv2 βhv(α + γ + p21 + p12 + µhd)
Nh2(α + p12 + p21)(γ + p12 + (1− g)p21)(α + µhd)(γ + µhd)
G4,8 =
αSv2 βhv(p12(α + γ + p21 + p12) + αγ− p21µhd)
Nh2(α + p12 + p21)(γ + p12 + (1− g)p21)(α + µhd)(γ + µhd)
G4,9 =
(p12 − µhd)Sv2 βhv
Nh2(γ + p12 + (1− g)p21)(γ + µhd)
G4,10 =
(γ + p12)Sv2 βhv
Nh2(γ + p12 + (1− g)p21)(γ + µhd)
Processes 2020, 8, 781 22 of 26
G7,1 =
ωSh1 βvh
(ω + µe)µv Nh1
, G7,3 =
εSh1 βvh






(ω + µe)µv Nh2
, G8,4 =
εSh2 βvh




Finally, the seasonal reproduction number Rs for the two-patch model is computed as the spectral
radius ρ of the next generation matrix G, i.e., Rs = ρ(G).
Proof of Theorem 3. Since the integrand of J is a convex function of U(t) = (u1(t), u2(t)) and the
state system satisfies the Lipschitz condition, the existence of the optimal controls can be proved by


















































































with λj(t f ) = 0 for j = 1, ..., 16 and evaluating the above system at the optimal controls and
corresponding states, one can obtain the adjoint system. Since the Hamiltonian H is minimized





= W3u1 + (λ3 − λ4)βhvSv1
Ih1
Nh1
+ (λ6 − λ7)βvhSh1
Iv1
Nh1
+ (λ11 − λ12)βhvSv2
Ih2
Nh2






= W4u2 − µv(λ3Sv1 + λ4Ev1 + λ5 Iv1 + λ11Sv2 + λ12Ev2 + λ13 Iv2).




























(λ3Sv1 + λ4Ev1 + λ5 Iv1 + λ11Sv2 + λ12Ev2 + λ13 Iv2)
By using the standard argument for bounds a ≤ ui ≤ b for i = 1, 2, we have the optimality
conditions.
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Appendix C. Optimal Control Result with Different Weight Constants
We consider various weight constants for the case that all of βhv, βhv and µv are controlled.
Figure A2a–c show the plots of u1 and u2 for W4 = 1000, 3000, 5000, when W1 = 1, W2 = 0.0001,
W3 = 1000 are fixed. One can see the similar results as in Section 3.3.










































2030 2031 2032 2033 2034 2035







2030 2031 2032 2033 2034 2035














2030 2031 2032 2033 2034 2035






2030 2031 2032 2033 2034 2035








































(a) Plot of u1 and u2 when W3 = 1000, W4 = 1000.
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(b) Plot of u1 and u2 when W3 = 1000, W4 = 3000.
Figure A2. Cont.
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(c) Plot of u1 and u2 when W3 = 1000, W4 = 5000.
Figure A2. The effect of different weight constant values on the optimal control functions.
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